IN2012DN02301A - - Google Patents

Download PDF

Info

Publication number
IN2012DN02301A
IN2012DN02301A IN2301DEN2012A IN2012DN02301A IN 2012DN02301 A IN2012DN02301 A IN 2012DN02301A IN 2301DEN2012 A IN2301DEN2012 A IN 2301DEN2012A IN 2012DN02301 A IN2012DN02301 A IN 2012DN02301A
Authority
IN
India
Prior art keywords
formula
compound
resulting
6alkyl
alkylating
Prior art date
Application number
Other languages
English (en)
Inventor
Augustinus De Kock Herman
Ferdinand Maria Filliers Walter
Albert Alex Aelterman Wim
Original Assignee
Janssen R & D Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen R & D Ireland filed Critical Janssen R & D Ireland
Publication of IN2012DN02301A publication Critical patent/IN2012DN02301A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/52Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
    • C07D263/54Benzoxazoles; Hydrogenated benzoxazoles
    • C07D263/58Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IN2301DEN2012 2003-09-30 2004-09-30 IN2012DN02301A (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03103630 2003-09-30
US50799603P 2003-10-02 2003-10-02
PCT/EP2004/052382 WO2005030739A1 (en) 2003-09-30 2004-09-30 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof

Publications (1)

Publication Number Publication Date
IN2012DN02301A true IN2012DN02301A (cs) 2015-08-14

Family

ID=34395298

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2301DEN2012 IN2012DN02301A (cs) 2003-09-30 2004-09-30

Country Status (24)

Country Link
US (1) US20070123574A1 (cs)
EP (1) EP1670773B1 (cs)
JP (1) JP4919802B2 (cs)
KR (1) KR101090102B1 (cs)
CN (1) CN1860107B (cs)
AP (1) AP1985A (cs)
AT (1) ATE353323T1 (cs)
AU (1) AU2004276017B2 (cs)
BR (1) BRPI0414916A (cs)
CA (1) CA2537877C (cs)
DE (1) DE602004004674T2 (cs)
DK (1) DK1670773T3 (cs)
EA (1) EA011891B1 (cs)
ES (1) ES2281828T3 (cs)
IL (1) IL173891A0 (cs)
IN (1) IN2012DN02301A (cs)
MX (1) MXPA06003575A (cs)
NO (1) NO20061951L (cs)
NZ (1) NZ546279A (cs)
PL (1) PL1670773T3 (cs)
PT (1) PT1670773E (cs)
SI (1) SI1670773T1 (cs)
WO (1) WO2005030739A1 (cs)
ZA (1) ZA200602603B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR053845A1 (es) * 2005-04-15 2007-05-23 Tibotec Pharm Ltd 5-tiazolilmetil[(1s,2r)-3-[[(2-amino-6-benzoxazolil)sulfonil)](2-metilpropil)amino]-2-hidroxi-1-(fenilmetil)propil]carbamato como mejorador de farmacos metabolizados por el citocromo p450
WO2011044134A1 (en) * 2009-10-05 2011-04-14 Albany Molecular Research, Inc. Epiminocycloalkyl(b)indole derivatives as serotonin sub-type 6 (5-ht6) modulators and uses thereof
AU2012207335A1 (en) 2011-01-19 2013-07-25 Albany Molecular Research, Inc. Benzofuro[3,2-c] pyridines and related analogs as serotonin sub-type 6 (5-HT6) modulators for the treatment of obesity, metabolic syndrome, cognition and schizophrenia
WO2014194519A1 (en) 2013-06-07 2014-12-11 Merck Sharp & Dohme Corp. Imidazole derivatives and methods of use thereof for improving pharmacokinetics of drug

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5968942A (en) * 1992-08-25 1999-10-19 G. D. Searle & Co. α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
NZ306027A (en) * 1995-03-10 1999-03-29 Searle & Co Heterocyclecarbonyl amino acid hydroxyethylamin sulfonamide derivatives, preparation and use as retroviral protease inhibitors
JP2000515488A (ja) * 1995-11-15 2000-11-21 ジー.ディー.サール アンド カンパニー 置換スルホニルアルカノイルアミノヒドロキシエチルアミノスルホンアミド レトロウイルスプロテアーゼ阻害剤
JP4008708B2 (ja) * 2000-04-07 2007-11-14 サムスン エレクトロニクス カンパニー リミテッド マトリックスメタロプロテイナーゼの阻害剤としてのスルホンアミド誘導体
US6455738B1 (en) * 2000-07-13 2002-09-24 Rhodia Chimie Process for the sulfonation of an aromatic compound
JP4530612B2 (ja) * 2001-02-14 2010-08-25 テイボテク・フアーマシユーチカルズ・リミテツド 広域スペクトルの2−(置換−アミノ)−ベンゾチアゾールスルホンアミドhivプロテアーゼインヒビター
CZ304524B6 (cs) * 2001-05-11 2014-06-18 Tibotec Pharmaceuticals Ltd. Derivát 2-aminobenzoxazolsulfonamidu, farmaceutická kompozice s jeho obsahem a léčivo pro léčení infekce retroviry
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors
MY142238A (en) * 2002-03-12 2010-11-15 Tibotec Pharm Ltd Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors

Also Published As

Publication number Publication date
DE602004004674T2 (de) 2007-11-22
WO2005030739A1 (en) 2005-04-07
SI1670773T1 (sl) 2007-06-30
ZA200602603B (en) 2008-05-28
KR101090102B1 (ko) 2011-12-07
PT1670773E (pt) 2007-05-31
PL1670773T3 (pl) 2007-06-29
NO20061951L (no) 2006-05-02
CA2537877C (en) 2015-03-17
ATE353323T1 (de) 2007-02-15
KR20060092224A (ko) 2006-08-22
MXPA06003575A (es) 2006-06-05
EP1670773B1 (en) 2007-02-07
EA011891B1 (ru) 2009-06-30
AU2004276017A1 (en) 2005-04-07
EA200600699A1 (ru) 2006-08-25
AP2006003603A0 (en) 2006-04-30
ES2281828T3 (es) 2007-10-01
CN1860107A (zh) 2006-11-08
JP4919802B2 (ja) 2012-04-18
US20070123574A1 (en) 2007-05-31
CN1860107B (zh) 2013-08-21
IL173891A0 (en) 2006-07-05
CA2537877A1 (en) 2005-04-07
DE602004004674D1 (de) 2007-03-22
BRPI0414916A (pt) 2006-11-07
DK1670773T3 (da) 2007-05-29
AU2004276017B2 (en) 2010-08-19
JP2007507468A (ja) 2007-03-29
AP1985A (en) 2009-03-30
EP1670773A1 (en) 2006-06-21
NZ546279A (en) 2008-09-26

Similar Documents

Publication Publication Date Title
MY138525A (en) Substituted acid derivatives useful as antidiabetic and antiobesity agents and method
EP0931788A3 (en) Metalloprotease inhibitors
WO2002049641A3 (en) Anti-endoparasitic amidoacetonitrils
SE0004245D0 (sv) Novel compounds and their use
WO1999000373A8 (en) Benzimidazole derivatives
NZ505103A (en) Phenylaminoalkylcarboxylic acid derivatives useful as beta 3 adrenoceptor stimulants
IN2012DN02301A (cs)
TW200621685A (en) Hydroxynaphthoic acid hydrazide compound and method for preparing the same
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
BR0009453A (pt) Processo para a preparação de um composto
MY130488A (en) Process for preparing 3,3',6,6'-tetraalkyl-2,2'-biphenols and 3,3',6,6'-tetraalkyl-5,5'-dihalo-2,2'-biphenols
WO2002060878A1 (fr) Derives de benzimidazolidinone
MXPA02001406A (es) Heterociclilos-2h-cromenos substituidos.
AU8459401A (en) Process for preparing a substituted imidazopyridine compound
SE0101323D0 (sv) New process
BR0315508A (pt) Processo para preparação de compostos de pirazol
EP0753514A4 (en) ALKYLENEDIAMINE DERIVATIVES
EP1471058A4 (en) PROCESS FOR PREPARING A 1,2,3-TRIAZOL COMPOUND
WO2001010862A3 (de) Substituierte heterocyclylbenzofurane
CA2390934A1 (en) Process for producing benzylamine compound
TWI256385B (en) Method and intermediate for preparing a prostaglandin f-type compound
AR028729A1 (es) Nuevo procedimiento para la preparacion de pirazolopirimidinonas
AP2000001960A0 (en) Process for the preparation of pyrazole(4,3-d)pyrimidin-7-ones-3-pyridylsulphonyl compounds and intermediates thereof.
NO20053117L (no) Cyklopenta[c]isoksazol-3-aminer anvendt som materialbeskyttelsesmidler..
IL164334A0 (en) Process for the preparation of 2-ethoxy-3-Ä4-(2-ämethanesulfonyloxyphenylüethoxy)phenylÜpropanoic acid